Healthcare company Bausch Health Companies Inc (NYSE/TSX:BHC) and its Ortho Dermatologics dermatology business reported on Thursday the receipt of approval from the US Food and Drug Administration (FDA) for the New Drug Application for DUOBRII Lotion, 0.01%/0.045% for the topical treatment of plaque psoriasis in adults.
Plaque psoriasis is a chronic, non-contagious skin disease that alters the life cycle of skin cells, causing them to build up rapidly on the surface of the skin.
According to Bausch Health, DUOBRII (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045% is the first and only topical lotion that contains a unique combination of halobetasol propionate and tazarotene in one formulation. A Phase 2 study demonstrated that the product was consistently more effective than its individual agents and vehicle in achieving treatment success.
In the company's year-long safety study, patients applied DUOBRII Lotion for up to 24 weeks of continuous use and up to 52 weeks of as-needed use.
Expected to be available in June 2019, DUOBRII Lotion is priced at USD825 for a supply of a 100-gram tube, which is more than 50% lower than other branded topical combination products. The company's access programme provides commercially insured patients with a co-pay between USD25 and USD40.
AbbVie's ELAHERE receives full US FDA approval
Johnson & Johnson's OPSYNVI receives US FDA approval
Outlook Therapeutics receives positive CHMP opinion for ONS-5010 in wet AMD treatment
Human Immunology Biosciences receives ODD from FDA for felzartamab
Eton Pharmaceuticals acquires PKU GOLIKE, expanding rare disease portfolio
Vertex receives FDA clearance for VX-407 Investigational New Drug Application for ADPKD
Phanes Therapeutics receives FDA Fast Track designation for PT886
Bio-Thera Solutions signs new licensing agreement with SteinCares
FDA accepts resubmission of Citius Pharmaceuticals, Inc's BLA for LYMPHIR
GSK Plc reports positive Phase III Jemperli data for endometrial cancer
ImmVira receives FDA Fast Track designation for MVR-T3011 IT